SCHEMBL7815098

SCHEMBL7815098

CCCOc1ccc2n[c]n(C)c2c1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FGFR1 P11362 2/20 0.44
LMNA P02545 3/20 0.38
TSHR P16473 1/20 0.38
HTT P42858 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
NPSR1 Q6W5P4 1/20 0.38
TUBB4A P04350 1/20 0.38
TUBB P07437 1/20 0.38
TUBA3C P0DPH7 1/20 0.38
TUBA1B P68363 1/20 0.38
TUBA4A P68366 1/20 0.38
TUBB4B P68371 1/20 0.38
TUBB3 Q13509 1/20 0.38
TUBB2A Q13885 1/20 0.38
TUBB8 Q3ZCM7 1/20 0.38
TUBA3E Q6PEY2 1/20 0.38
TUBA1A Q71U36 1/20 0.38
TUBA1C Q9BQE3 1/20 0.38
TUBB6 Q9BUF5 1/20 0.38
TUBB2B Q9BVA1 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7810936 0.94 FGFR1 (0.44) FGFR1MAPK1LTA4HPDE2AGPBAR1
SCHEMBL7812089 0.88 FGFR1 (0.50) FGFR1LMNATSHRHTTSMN1; SMN2
SCHEMBL7814303 0.88 MAPT (0.48) LMNATSHRHTTSMN1; SMN2MEN1
SCHEMBL7805179 0.82 FGFR1 (0.50) FGFR1MAPK1RAD51MAPTLTA4H
SCHEMBL7815075 0.81 FGFR1 (0.43) FGFR1MAPK1LTA4HPDE2AGPBAR1
SCHEMBL7815130 0.81 TRIM24 (0.44) LMNATSHRSMN1; SMN2MAPK1MEN1
SCHEMBL7815337 0.79 ALDH1A1 (0.43) LMNAHTTSMN1; SMN2NPSR1MAPK1
SCHEMBL7805459 0.78 NPC1 (0.49) MEN1KMT2AMAOB
SCHEMBL7814533 0.77 GPBAR1 (0.36) FGFR1SMN1; SMN2MAPTPDE2AGPBAR1
SCHEMBL7805417 0.75 BRD4 (0.47) FGFR1KMT2APDE2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0745600-B1 Benzimidazole derivatives, their preparation and their therapeutic use SANKYO CO (JP) 2001-10-24 EP disclosed
CN-1066729-C Benzimidazole derivatives, their preparation and their therapeutic use SANKYO CO (JP) 2001-06-06 CN disclosed
US-5886014-A TREATMENT AND/OR PROPHYLAXIS OF A VARIETY OF DISORDERS, INCLUDING HYPERLIPEMIA, HYPERGLYCEMIA, OBESITY, IMPAIRED GLUCOSE TOLERANCE (IGT), INSULIN RESISTANCE AND DIABETIC COMPLICATIONS SANKYO COMPANY, LIMITED (JP) 1999-03-23 US disclosed
CN-1157288-A Benzimidazole derivatives, their preparation and their therapeutic use SANKYO CO (JP) 1997-08-20 CN disclosed
EP-0745600-A1 Benzimidazole derivatives, their preparation and their therapeutic use SANKYO COMPANY LIMITED (JP) 1996-12-04 EP disclosed